Bliss GVS Pharma share price
You have to be logged in to add this to Watchlist.- ₹172.00(4.62%)January 16, 2026 15:29:58 PM IST
- NSE
- BSE
- Vol : 4.56 M (NSE + BSE)Last 20 day avg : 10.32 M
Bliss GVS Pharma is trading 4.62% upper at Rs 172.00 as compared to its last closing price. Bliss GVS Pharma has been trading in the price range of 174.25 & 162.95. Bliss GVS Pharma has given 0.59% in this year & -11.94% in the last 5 days. Bliss GVS Pharma has TTM P/E ratio 14.66 as compared to the sector P/E of 22.69.The company posted a net profit of 27.25 Crores in its last quarter.Listed peers of Bliss GVS Pharma include Divi's Laboratories (-1.93%), Sun Pharmaceutical Industries (-1.84%), Torrent Pharmaceuticals (0.35%).The Mutual Fund holding in Bliss GVS Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Bliss GVS Pharma was at 13.27% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 17, 2026, 02:10 AM UTC
- BetaMedium volatility1.10Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.08The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.30Annual dividends as a percentage of the stock price.
- P/BHigher than historical values1.65The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values15.94Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.21The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bearish | 6,233.95 | -1.93 | 1,65,491.79 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bearish | 1,669.20 | -1.84 | 4,00,487.56 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,018.75 | 0.35 | 1,36,007.30 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Bearish | 1,175.65 | -0.91 | 98,110.38 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Bearish | 1,398.45 | -2.52 | 1,12,922.46 | 22.95 | 3.87 | 0.87 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-06 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results & Others |
| 2024-10-24 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE416D01022
- BSE Code506197
- NSE CodeBLISSGVS
Bliss GVS Pharma is trading at 172.00 as on Fri Jan 16 2026 09:59:58. This is 4.62% upper as compared to its previous closing price of 164.40.
The market capitalization of Bliss GVS Pharma is 1821.16 Cr as on Fri Jan 16 2026 09:59:58.
The 52 wk high for Bliss GVS Pharma is 195.85 whereas the 52 wk low is 105.05
Bliss GVS Pharma can be analyzed on the following key metrics -
- TTM P/E: 14.66
- Sector P/E: 22.69
- Dividend Yield: 0.30%
- D/E ratio: 0.05
Bliss GVS Pharma reported a net profit of 84.30 Cr in 2025.
EQUITY QUICK LINKS
Bliss GVS Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.